Compass Therapeutics Participation in Key Healthcare Event
Boston-based Compass Therapeutics, Inc. (Nasdaq: CMPX), an emerging player in the oncology biopharmaceutical realm, is gearing up for an important presentation at the Piper Sandler 36th Annual Healthcare Conference. This significant event will take place in New York City over a three-day span.
Presentation Insights and Schedule
On December 4, 2024, from 9:50 to 10:10 AM EST, Compass Therapeutics will take the stage to discuss their innovative approaches to cancer treatment. The company’s presentation is anticipated to draw considerable interest due to its focus on unique antibody-based therapeutics designed to address key challenges in oncology.
Accessing the Presentation
The corporate presentation will be accessible virtually, ensuring that stakeholders, investors, and curious attendees can view it remotely. For those unable to participate live, the session will be archived for 90 days, allowing broader access to the cutting-edge insights presented.
About Compass Therapeutics
Compass Therapeutics is not merely a name in the industry; it represents a vision for innovative cancer treatments. The company focuses on the interplay between angiogenesis, the immune system, and tumor growth, aiming to develop proprietary therapeutics that can effectively treat a range of malignancies.
The Therapeutic Pipeline
Compass Therapeutics is committed to advancing its pipeline of novel antibody products. This commitment involves targeting critical biological pathways crucial for fostering a robust anti-tumor response. Their strategic approach includes utilizing agents that modulate the microvasculature and stimulate potent immune responses while negating immunosuppressive tactics employed by tumors.
History and Future Directions
Founded in 2014, Compass Therapeutics has made significant strides in the field of oncology. Headquartered in Boston, the company emphasizes a blend of clinical and nonclinical data to support its development of both standalone therapies along with combinations that incorporate their proprietary pipeline antibodies.
The Team Behind the Innovation
The company is spearheaded by a team of experts in oncology and immunology, dedicating their efforts to push the boundaries of cancer treatment. Their innovative science reflects a passion for improving patient outcomes and addressing unmet needs in oncology therapeutics.
Investor and Media Contacts
Compass Therapeutics remains open to dialogue with investors and media personnel alike. For investor inquiries, reach out via email at ir@compasstherapeutics.com. Media representatives can contact Anna Gifford at media@compasstherapeutics.com or by phone at 617-500-8099, ensuring all communication pathways are clear and accessible.
Frequently Asked Questions
What is the Piper Sandler Healthcare Conference?
The Piper Sandler Healthcare Conference is an annual event that brings together healthcare industry leaders to discuss advancements and innovations in the field.
What will Compass Therapeutics present at the conference?
Compass Therapeutics will showcase its proprietary antibody-based therapies aimed at treating various cancers and discuss its strategic direction.
How can I access the presentation by Compass Therapeutics?
The presentation will be available online and archived for 90 days after the live event, making it accessible for later viewing.
What is the focus of Compass Therapeutics?
Compass Therapeutics focuses on developing novel cancer treatments that exploit the mechanisms of angiogenesis and immunology to enhance anti-tumor responses.
How do I contact Compass Therapeutics for more information?
For investor relations, contact ir@compasstherapeutics.com, and for media inquiries, reach Anna Gifford at media@compasstherapeutics.com.
